Profile

NeoSci Ventures is a biotech venture builder based in Singapore, founded by Daphne Teo and Dr. Timothy Lu. They operate across Singapore, Taiwan, and the US, leveraging their extensive network in the biotech industry. The team comprises individuals with 15 years of experience in building and investing in biotech companies, contributing to businesses that have raised billions of dollars and achieved multiple public listings and acquisitions. NSV also operates NSG BioLabs, a co-working laboratory platform in Singapore for biotechnology companies.

NeoSci Ventures focuses on investing in biotechnology and healthcare companies, particularly in therapeutic candidates and technologies at the intersection of biology, artificial intelligence, data, and scientific tools. They target companies in the US and Asia, engaging with assets that aim to replenish pharmaceutical groups' pipelines. With a capital deployment strategy in place, NSV partakes in the early stages to bring potential discoveries into market-ready products. Their total assets under management include the newly launched Biotech Ventures Fund of $53 million.

Some of the notable portfolio companies include Protuoso, co-founded by NSV to develop protein-based therapeutics for complex diseases. Though not all investments are publicly disclosed, their strategic focus remains within their sphere of expertise in the biotechnology and healthcare sectors.

Industry

AI Healthcare Services Biotechnology Data infra MedTech

NeoSci Ventures Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Debut Biotech Fund
Venture Capital (VC)
Biotechnology
Healthcare Services
AI
Seed
Series A
North America
Asia
$1-5 m
$53 M
November 2026

Contacts

Name
Title
Email
Upgrade to see contacts
avatar
KaMReTdcPmOV63yG KaMReTdcPmOV63yG
KaMReTdcPmOV63yG
avatar
KaMReTdcPmOV63yG KaMReTdcPmOV63yG
KaMReTdcPmOV63yG
avatar
KaMReTdcPmOV63yG KaMReTdcPmOV63yG
KaMReTdcPmOV63yG
avatar
KaMReTdcPmOV63yG KaMReTdcPmOV63yG
KaMReTdcPmOV63yG
avatar
KaMReTdcPmOV63yG KaMReTdcPmOV63yG
KaMReTdcPmOV63yG
Investment-team contacts for NeoSci Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about NeoSci Ventures

NeoSci Ventures is a venture capital firm. It backs companies at Seed and Series A, writing tickets of $10-50 m.
NeoSci Ventures is located in Singapore, Singapore, Singapore.
NeoSci Ventures was founded in .
NeoSci Ventures invests in companies and startups in AI, Healthcare Services, Biotechnology, Data infra, MedTech.
NeoSci Ventures invests in companies and startups in North America, Asia.
NeoSci Ventures invests in companies and startups at Seed, Series A.
NeoSci Ventures usually invests $10-50 m on average.
NeoSci Ventures has around $53m assets under management.
NeoSci Ventures last fund was created/launched in 2026-11-03
Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for NeoSci Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query NeoSci Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 19 November, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.